NASDAQ: MLABMesa Laboratories Inc Stock Ownership - Who owns Mesa Laboratories?
Insider buying vs selling
Have Mesa Laboratories Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John Sakys | CFO | 2026-06-16 | 1,223 | $101.27 | $123.85kSell |
| Lyndsey Elizabeth Crennen | CAO | 2026-06-16 | 118 | $101.27 | $11.95kSell |
| Brian David Archbold | SVP Operations | 2026-06-16 | 1,151 | $101.27 | $116.56kSell |
| John Sakys | CFO | 2026-06-15 | 2,717 | $104.08 | $282.79kBuy |
| Brian David Archbold | SVP Operations | 2026-06-15 | 2,454 | $104.08 | $255.41kBuy |
| R. Tony Tripeny | Director | 2026-03-10 | 1,315 | $76.00 | $99.94kBuy |
| Mark Christopher Capone | Director | 2026-03-10 | 1,301 | $76.35 | $99.33kBuy |
| Shiraz Shabanali Ladiwala | Director | 2026-03-10 | 3,500 | $72.23 | $252.81kBuy |
MLAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when MLAB insiders and whales buy or sell their stock.
MLAB Shareholders
What type of owners hold Mesa Laboratories Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Long Path Partners LP | 7.34% | 405,583 | $38.57M | Institution |
| Blackrock Inc | 7.13% | 393,851 | $37.46M | Institution |
| Boston Partners | 4.86% | 268,711 | $25.55M | Institution |
| Select Equity Group LP | 4.27% | 235,885 | $22.43M | Institution |
| Vanguard Capital Management LLC | 4.21% | 232,643 | $22.12M | Institution |
| Ranger Investment Management LP | 3.67% | 202,903 | $19.30M | Institution |
| Evan Guillemin | 3.63% | 200,512 | $19.07M | Insider |
| Luke R. Schmieder | 3.19% | 176,293 | $16.77M | Insider |
| Aqr Capital Management LLC | 3.09% | 170,562 | $16.22M | Institution |
| Morgan Stanley | 2.93% | 162,116 | $15.42M | Institution |
MLAB vs Scientific & Technical Instrument Stocks
Mesa Laboratories Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.